Background illustration for clinical trials search

Paid Clinical Trials Los Angeles

Discover 3,580 paid clinical trials in Los Angeles, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular Carcinoma

for
Hepatocellular Carcinoma, HCC
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT04472767

Phase 2, Recruiting

DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia

for
Leukemia, Myeloid, Acute
Location: Orange CA, Winston-Salem NC, Charlottesville VA,
Sponsor: Delta-Fly Pharma, Inc.

Sex: All

Age: 18+

Code: NCT06382168

Phase 1, Phase 2, Recruiting

Single-Center Eval of Clinical & Radiological Benefit AHCC in Combo W/ SOC Tx for HPV+ Pts W/ HNSCC

for
HNSCC, Head and Neck Squamous Cell Carcinoma
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18 - 70+

Code: NCT06693323

Phase 2, Recruiting

Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors

for
Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Neoplasm,
Location: Orange CA, Irvine CA, City of Saint Peters MO,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05687123

Phase 1, Recruiting

Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)

for
Myelodysplastic Syndrome
Location: Orange CA, Irvine CA, Salt Lake City UT, Albuquerque NM,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06577441

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia

for
Acute Lymphoblastic Leukemia, Hepatotoxicity
Location: Orange CA
Sponsor: Children's Hospital of Orange County

Sex: All

Age: 5 - 29

Code: NCT05501899

Early Phase 1, Recruiting

De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx

for
HPV Positive Oropharyngeal Squamous Cell Carcinoma
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT05600842

Recruiting

Groningen International Study on Sentinel Nodes in Vulvar Cancer-III

for
Vulvar Cancer, Sentinel Lymph Node, Lymph Node Metastases
Location: Orange CA, Las Vegas NV, Oklahoma City OK, Omaha NE,
Sponsor: University Medical Center Groningen

Sex: Female

Age: 18+

Code: NCT05076942

Phase 2, Recruiting

A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease

for
Acute Myeloid Leukemia,
Location: Orange CA, Salt Lake City UT, Oklahoma City OK,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05886049

Phase 1, Recruiting

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

for
Breast Cancer, Sarcoma, Gastric Cancer, Lung Cancer,
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT06580002

Phase 2, Recruiting

Patient-Derived Xenografts to Reduce Cancer Health Disparities

for
Bladder Carcinoma, Gastric Carcinoma,
Location: Orange CA, Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 21 - 70+

Code: NCT04410302

Recruiting

Assess Diversity of Gut Microbiome in Met NSCLC in Correlation to Tx & Adverse Effects

for
Non Small Cell Lung Cancer
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT06221800

Recruiting

PhI Pilot Study Pafolacianine Inject for Intraoperative Imaging on Outcomes of GI Cancer Peritoneal Carcinomatosis

for
Gastrointestinal Cancer, Peritoneal Carcinomatosis
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT06511037

Early Phase 1, Recruiting

Multidimensional Classification of Mild Traumatic Brain Injury (mTBI)

for
Mild Traumatic Brain Injury
Location: Los Angeles CA
Sponsor: Clea Tucker

Sex: All

Age: 18 - 50

Code: NCT04874389

Recruiting

Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas

for
Colon Adenocarcinoma, Colorectal Cancer
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT04920032

Phase 1, Recruiting

Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer

for
Metastatic Microsatellite Stable Colorectal Carcinoma,
Location: Orange CA, Irvine CA, Cincinnati OH, West Chester OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06654037

Phase 1, Recruiting

Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2

for
Neurotrophic Keratopathy
Location: Laguna Hills CA, Loma Linda CA, Medford OR, Portland OR,
Sponsor: ReGenTree, LLC

Sex: All

Age: 18+

Code: NCT05555589

Phase 3, Recruiting
New

Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial

for
Richter Syndrome,
Location: Orange CA, Irvine CA, Laguna Hills CA,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT07220187

Phase 3, Recruiting

A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

for
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Location: Orange CA, Palo Alto CA, Sacramento CA, Denver CO,
Sponsor: Nuvalent Inc.

Sex: All

Age: 12+

Code: NCT05118789

Phase 1, Phase 2, Recruiting

Acupuncture Therapy and Hypertension

for
Mild to Moderate Hypertension
Location: Orange CA, Irvine CA
Sponsor: University of California, Irvine

Sex: All

Age: 45 - 70+

Code: NCT05530512

Recruiting

With a vast healthcare network and top-tier medical research centers, Los Angeles is a key hub for a wide range of clinical trials. Renowned institutions such as UCLA Health, Cedars-Sinai Medical Center, and the Keck School of Medicine at USC lead pioneering research across various fields, including cancer, cardiovascular health, and neuroscience.

Many Los Angeles medical centers are at the forefront of innovative studies, positioning the city as a critical location for advancing medical research and improving patient care outcomes.

Why choose Los Angeles for clinical trials?

Los Angeles offers distinct advantages for individuals participating in clinical trials. The city’s diverse population provides a wide range of participants, enhancing the accuracy and applicability of research findings across different demographics.

Known for its forward-thinking research environment, Los Angeles is home to leading institutions that drive cutting-edge studies in a variety of medical fields. By choosing to participate in a clinical trial in Los Angeles, individuals contribute to groundbreaking medical research while benefiting from the city's well-established clinical research infrastructure and access to world-class healthcare professionals.

Common conditions studied in Los Angeles

Local regulations and guidelines

Benefits of participating in clinical trials

How to enroll in a clinical trial in Los Angeles